The Newsroom
Item 1 of 3
AdventHealth Research Institute Offers Phase II Clinical Trial of Etanercept for Treatment of Blast-Induced Tinnitus
Approximately 1 billion people throughout the world suffer from tinnitus (ringing in the ears), and it is the number one disability of those who serve in the U.S. military. The condition can disrupt...
Item 2 of 3
AdventHealth’s Karen D. Corbin, PhD, RD, Contributed to New American Diabetes Association Consensus Statement on Liver Disease in Diabetes
Item 3 of 3
AdventHealth East Orlando First in Florida to Earn Advanced Foot & Ankle Surgery Certification from DNV
Recent Stories at AdventHealthMD
-
-
AdventHealth research contributes to approval of first FDA-approved drug to delay onset of Type 1 diabetes
-
AdventHealth Celebration First in Central Florida to Offer Vaginal Hysterectomy Using the Anovo™ Surgical System
-
Regional organization tours AdventHealth Mission Control as part of upcoming feature on innovation
-
AdventHealth receives the Healthcare Innovation of the Year award for the world’s first-ever virtual advanced MRI program
-
AdventHealth physician receives national award for his exceptional dedication to lifestyle medicine
-
AdventHealth First in Central Florida to Implant Dual-Chamber Leadless Pacemaker as Part of AVEIR DR i2i Clinical Trial
-
AdventHealth First in Florida to Successfully Implant Thoraflex™ Hybrid Device in Patient with Complex Aortic Arch Dissection
-
AdventHealth Chief Science Officer receives national award related to obesity research